COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Debt / NOTE 1.500% 4/1
Number of holders
19
Total 13F principal, excl. options
190M
Principal change
-17.3M
Total reported value, excl. options
$123M
Value change
-$7.74M
Number of buys
6
Number of sells
-8
Price
$0.61

Significant Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q3 2023

24 filings reported holding 19249HAB9 - COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q3 2023.
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 has 19 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $190M of principal .
Largest 10 bondholders include LAZARD ASSET MANAGEMENT LLC ($36.5M of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($31.6M of principal), UBS ASSET MANAGEMENT AMERICAS INC ($30M of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($20.7M of principal), COURAGE CAPITAL MANAGEMENT LLC ($18M of principal), AQR Arbitrage LLC ($10.3M of principal), OAKTREE CAPITAL MANAGEMENT LP ($10.3M of principal), D. E. Shaw & Co., Inc. ($10M of principal), GABELLI FUNDS LLC ($7.5M of principal), and ADVENT CAPITAL MANAGEMENT /DE/ ($6.07M of principal).
This table shows the top 19 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.